1
|
Rocha JP, da Silva PDC, Pascoal-Xavier MA, Bicalho KA, Alves ÉAR. Lidocaine exhibits antileishmanial and immunomodulatory activities in an in vitro model of tegumentary leishmaniasis. Acta Trop 2025; 266:107645. [PMID: 40339877 DOI: 10.1016/j.actatropica.2025.107645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Revised: 04/17/2025] [Accepted: 05/05/2025] [Indexed: 05/10/2025]
Abstract
Local anesthetics have been shown to inhibit or delay the progression of tegumentary leishmaniasis (TL) in hamster models, although the mechanisms underlying this clinical improvement remain unclear. This study aimed to determine whether lidocaine reduces intracellular parasitism through a direct antiparasitic effect and/or by modulating macrophage functions. To achieve this, Leishmania (L.) amazonensis promastigotes were exposed to increasing concentrations (0.078 to 5.0 mg/mL) of lidocaine for up to 72 hours, followed by assessments of parasite proliferation and viability. Next, human macrophages were incubated for 24 and 72 hours with escalating concentrations (0.078 to 5.0 mg/mL) of lidocaine to determine the maximum non-cytotoxic concentration (MNCC). Subsequently, L. (L.) amazonensis-infected human macrophages were treated with the MNCC of lidocaine for 24 and 72 hours, and the infection index, nitric oxide (NO) and cytokine levels, and intracellular parasite viability were measured. The results showed that lidocaine caused a dose-dependent reduction in the proliferation and viability of L. (L.) amazonensis promastigotes. The IC50 values for proliferation decreased from 0.69 mg/mL at 24 hours to 0.13 mg/mL at 72 hours, while the IC50 values for viability declined from 1.08 mg/mL at 24 hours to 0.30 mg/mL at 72 hours. These findings indicate that prolonged exposure enhances the parasite's susceptibility to lidocaine's antiproliferative and cytotoxic effects. The MNCC of lidocaine for human macrophages was determined to be 0.625 mg/mL. After incubating infected macrophages with this concentration, the mean ± standard deviation of the infection index was reduced by over 66% after both 24-hour and 72-hour treatments. Additionally, after 72 hours of exposure to lidocaine, there was an 89.6% increase in NO production by infected macrophages. Infected macrophages exposed to lidocaine produced 7.9-fold less IL-1β after 24 hours of treatment, and 35.2-fold, 12.9-fold, and 1.6-fold less TNF-α, IL-6, and IL-8, respectively, after 72 hours of treatment. The number of promastigotes that proliferated from intracellular amastigotes was significantly lower following treatment with lidocaine for both 24 and 72 hours, indicating that lidocaine significantly reduces the viability of intracellular parasites. In conclusion, lidocaine exhibits potent anti-Leishmania activity and modulates macrophage functions crucial to the immunity against Leishmania and immunopathogenesis of TL. These findings support its potential as an alternative or adjunctive therapeutic strategy for the treatment of this disease.
Collapse
Affiliation(s)
- Juliane Pereira Rocha
- Grupo de Pesquisa em Imunologia Celular e Molecular, Instituto René Rachou/FIOCRUZ-Minas, Belo Horizonte, Minas Gerais, Brazil.
| | - Priscila de Cássia da Silva
- Grupo de Pesquisa em Imunologia Celular e Molecular, Instituto René Rachou/FIOCRUZ-Minas, Belo Horizonte, Minas Gerais, Brazil.
| | - Marcelo Antônio Pascoal-Xavier
- Grupo de Pesquisa em Imunologia das Doenças Virais, Instituto René Rachou/FIOCRUZ-Minas, Belo Horizonte, Minas Gerais, Brazil.
| | - Kelly Alves Bicalho
- Grupo de Pesquisa em Imunologia Celular e Molecular, Instituto René Rachou/FIOCRUZ-Minas, Belo Horizonte, Minas Gerais, Brazil.
| | - Érica Alessandra Rocha Alves
- Grupo de Pesquisa em Imunologia Celular e Molecular, Instituto René Rachou/FIOCRUZ-Minas, Belo Horizonte, Minas Gerais, Brazil.
| |
Collapse
|
2
|
Abstract
Immune principles formulated by Jenner, Pasteur, and early immunologists served as fundamental propositions for vaccine discovery against many dreadful pathogens. However, decisive success in the form of an efficacious vaccine still eludes for diseases such as tuberculosis, leishmaniasis, and trypanosomiasis. Several antileishmanial vaccine trials have been undertaken in past decades incorporating live, attenuated, killed, or subunit vaccination, but the goal remains unmet. In light of the above facts, we have to reassess the principles of vaccination by dissecting factors associated with the hosts' immune response. This chapter discusses the pathogen-associated perturbations at various junctures during the generation of the immune response which inhibits antigenic processing, presentation, or remodels memory T cell repertoire. This can lead to ineffective priming or inappropriate activation of memory T cells during challenge infection. Thus, despite a protective primary response, vaccine failure can occur due to altered immune environments in the presence of pathogens.
Collapse
Affiliation(s)
| | - Sunil Kumar
- National Centre for Cell Science, Pune, Maharashtra, India
| | | | - Bhaskar Saha
- National Centre for Cell Science, Pune, Maharashtra, India.
- Trident Academy of Creative Technology, Bhubaneswar, Odisha, India.
| |
Collapse
|
3
|
Cytokine saga in visceral leishmaniasis. Cytokine 2020; 147:155322. [PMID: 33127259 DOI: 10.1016/j.cyto.2020.155322] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 09/21/2020] [Accepted: 09/25/2020] [Indexed: 12/12/2022]
Abstract
In humans, infection with Leishmania manifests into a spectrum of diseases. The manifestation of the diseases depend on the resultant evasion of the parasite to immune responses namely by macrophages, which is an exclusive host of Leishmania. The B cells valiantly mount antibody responses, however, to no avail as the Leishmania parasites occupy the intracellular niches of the macrophages and subvert the immune response. Extensive studies have been documented on the role of cell-mediated immunity (CMI) in protection and counter survival strategies of the parasites leading to downregulation of CMI. The present review attempts to discuss the cytokines in progression or resolution of visceral form of leishmaniasis or kala-azar, predominantly affecting the Indian subcontinent. The components/cytokine(s) responsible for the regulation of the critical balance of T helper cells and their subsets have been discussed in the perspective. Therefore, any strategy involving the treatment of visceral leishmania (VL) needs to consider the balance and regulation of T cell function.
Collapse
|
4
|
Nadaes NR, Silva da Costa L, Santana RC, LaRocque-de-Freitas IF, Vivarini ÁDC, Soares DC, Wardini AB, Gazos Lopes U, Saraiva EM, Freire-de-Lima CG, Decote-Ricardo D, Pinto-da-Silva LH. DH82 Canine and RAW264.7 Murine Macrophage Cell Lines Display Distinct Activation Profiles Upon Interaction With Leishmania infantum and Leishmania amazonensis. Front Cell Infect Microbiol 2020; 10:247. [PMID: 32596164 PMCID: PMC7303514 DOI: 10.3389/fcimb.2020.00247] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2019] [Accepted: 04/29/2020] [Indexed: 11/15/2022] Open
Abstract
Leishmaniasis is an anthropozoonotic disease, and dogs are considered the main urban reservoir of the parasite. Macrophages, the target cells of Leishmania sp., play an important role during infection. Although dogs have a major importance in the epidemiology of the disease, the majority of the current knowledge about Leishmania–macrophage interaction comes from murine experimental models. To assess whether the canine macrophage strain DH82 is an accurate model for the study of Leishmania interaction, we compared its infection by two species of Leishmania (Leishmania infantum and L. amazonensis) with the murine macrophage cell line (RAW264.7). Our results demonstrated that L. amazonensis survival was around 40% at 24 h of infection inside both macrophage cell lines; however, a reduction of 4.3 times in L. amazonensis infection at 48 h post-infection in RAW 264.7 macrophages was observed. The survival index of L. infantum in DH82 canine macrophages was around 3 times higher than that in RAW264.7 murine cells at 24 and 48 h post-infection; however, at 48 h a reduction in both macrophages was observed. Surprisingly at 24 h post-infection, NO and ROS production by DH82 canine cells stimulated with LPS or menadione or during Leishmania infection was minor compared to murine RAW264.7. However, basal arginase activity was higher in DH82 cells when compared to murine RAW264.7 cells. Analysis of the cytokines showed that these macrophages present a different response profile. L. infantum induced IL-12, and L. amazonensis induced IL-10 in both cell lines. However, L. infantum and L. amazonensis also induced TGF-β in RAW 264.7. CD86 and MHC expression showed that L. amazonensis modulated them in both cell lines. Conversely, the parasite load profile did not show significant difference between both macrophage cell lines after 48 h of infection, which suggests that other mechanisms of Leishmania control could be involved in DH82 cells.
Collapse
Affiliation(s)
- Natalia Rocha Nadaes
- Instituto de Veterinária, Universidade Federal Rural Do Rio de Janeiro, Seropédica, Brazil
| | - Leandro Silva da Costa
- Instituto de Bioquímica Médica Leopoldo De Meis, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Raissa Couto Santana
- Instituto de Veterinária, Universidade Federal Rural Do Rio de Janeiro, Seropédica, Brazil
| | | | | | - Deivid Costa Soares
- Instituto de Microbiologia Paulo de Góes, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Amanda Brito Wardini
- Instituto de Veterinária, Universidade Federal Rural Do Rio de Janeiro, Seropédica, Brazil
| | - Ulisses Gazos Lopes
- Instituto de Biofísica Carlos Chagas Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Elvira M Saraiva
- Instituto de Microbiologia Paulo de Góes, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - Debora Decote-Ricardo
- Instituto de Veterinária, Universidade Federal Rural Do Rio de Janeiro, Seropédica, Brazil
| | | |
Collapse
|
5
|
Toledo MDS, Cronemberger-Andrade A, Barbosa FMC, Reis NFDC, Dupin TV, Soares RP, Torrecilhas AC, Xander P. Effects of extracellular vesicles released by peritoneal B-1 cells on experimental Leishmania (Leishmania) amazonensis infection. J Leukoc Biol 2020; 108:1803-1814. [PMID: 32356366 DOI: 10.1002/jlb.3ma0220-464rr] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2020] [Revised: 02/25/2020] [Accepted: 03/26/2020] [Indexed: 02/06/2023] Open
Abstract
B-1 cells are a B-lymphocyte subtype whose roles in immunity are not completely defined. These cells can produce cytokines (mainly IL-10) and natural and specific antibodies. Currently, extracellular vesicles (EVs) released by immune cells have emerged as new important entities in cell-cell communication. Immune cells release EVs that can activate and/or modulate other immune cells. Here, we characterized the EVs released by peritoneal B-1 cells infected or not with Leishmania (Leishmania) amazonensis. This Leishmania species causes cutaneous leishmaniasis and can infect macrophages and B-1 cells. Our results showed that peritoneal B-1 cells spontaneously release EVs, but the parasite stimulated an increase in EVs production by peritoneal B-1 cells. The treatment of BALB/c and C57BL/6 bone marrow-derived macrophages (BMDM) with EVs from infected peritoneal B-1 cells led to differential expression of iNOS, IL-6, IL-10, and TNF-α. Additionally, BALB/c mice previous treated with EVs released by peritoneal B-1 cells showed a significant lower lesion size and parasite burden. Thus, this study demonstrated that peritoneal B-1 cells could release EVs that can alter the functions of macrophages in vitro and in vivo these EVs altered the course of L. amazonensis infection. These findings represent the first evidence that EVs from peritoneal B-1 cells can act as a new mechanism of cellular communication between macrophages and B-1 cells, contributing to immunity against experimental leishmaniasis.
Collapse
Affiliation(s)
- Maytê Dos Santos Toledo
- Department of Pharmaceutical Sciences, Federal University of São Paulo campus Diadema, Diadema, São Paulo, Brazil
| | | | | | | | - Talita Vieira Dupin
- Department of Pharmaceutical Sciences, Federal University of São Paulo campus Diadema, Diadema, São Paulo, Brazil
| | - Rodrigo Pedro Soares
- Laboratory of Cellular and Molecular Parasitology, René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Minas Gerais, Brazil
| | - Ana Claudia Torrecilhas
- Department of Pharmaceutical Sciences, Federal University of São Paulo campus Diadema, Diadema, São Paulo, Brazil.,Department of Medicine/Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil
| | - Patricia Xander
- Department of Pharmaceutical Sciences, Federal University of São Paulo campus Diadema, Diadema, São Paulo, Brazil
| |
Collapse
|
6
|
Smirlis D, Dingli F, Pescher P, Prina E, Loew D, Rachidi N, Späth GF. SILAC-based quantitative proteomics reveals pleiotropic, phenotypic modulation in primary murine macrophages infected with the protozoan pathogen Leishmania donovani. J Proteomics 2019; 213:103617. [PMID: 31846769 DOI: 10.1016/j.jprot.2019.103617] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2019] [Revised: 12/04/2019] [Accepted: 12/13/2019] [Indexed: 01/06/2023]
Abstract
Leishmaniases are major vector-borne tropical diseases responsible for great human morbidity and mortality, caused by protozoan, trypanosomatid parasites of the genus Leishmania. In the mammalian host, parasites survive and multiply within mononuclear phagocytes, especially macrophages. However, the underlying mechanisms by which Leishmania spp. affect their host are not fully understood. Herein, proteomic alterations of primary, bone marrow-derived BALB/c macrophages are documented after 72 h of infection with Leishmania donovani insect-stage promastigotes, applying a SILAC-based, quantitative proteomics approach. The protocol was optimised by combining strong anion exchange and gel electrophoresis fractionation that displayed similar depth of analysis (combined total of 6189 mouse proteins). Our analyses revealed 86 differentially modulated proteins (35 showing increased and 51 decreased abundance) in response to Leishmania donovani infection. The proteomics results were validated by analysing the abundance of selected proteins. Intracellular Leishmania donovani infection led to changes in various host cell biological processes, including primary metabolism and catabolic process, with a significant enrichment in lysosomal organisation. Overall, our analysis establishes the first proteome of bona fide primary macrophages infected ex vivo with Leishmania donovani, revealing new mechanisms acting at the host/pathogen interface. SIGNIFICANCE: Little is known on proteome changes that occur in primary macrophages after Leishmania donovani infection. This study describes a SILAC-based quantitative proteomics approach to characterise changes of bone marrow-derived macrophages infected with L. donovani promastigotes for 72 h. With the application of SILAC and the use of SAX and GEL fractionation methods, we have tested new routes for proteome quantification of primary macrophages. The protocols developed here can be applicable to other diseases and pathologies. Moreover, this study sheds important new light on the "proteomic reprogramming" of infected macrophages in response to L. donovani promastigotes that affects primary metabolism, cellular catabolic processes, and lysosomal/vacuole organisation. Thus, our study reveals key molecules and processes that act at the host/pathogen interface that may inform on new immuno- or chemotherapeutic interventions to combat leishmaniasis.
Collapse
Affiliation(s)
- Despina Smirlis
- Institut Pasteur and Institut National de Santé et Recherche Médicale INSERM U1201, Unité de Parasitologie Moléculaire et Signalisation, Paris, France; Hellenic Pasteur Institute, Molecular Parasitology Laboratory, Athens, Greece.
| | - Florent Dingli
- Laboratoire de Spectrométrie de Masse Protéomique, Centre de Recherche, Institut Curie, Université de recherche PSL, Paris, France
| | - Pascale Pescher
- Institut Pasteur and Institut National de Santé et Recherche Médicale INSERM U1201, Unité de Parasitologie Moléculaire et Signalisation, Paris, France
| | - Eric Prina
- Institut Pasteur and Institut National de Santé et Recherche Médicale INSERM U1201, Unité de Parasitologie Moléculaire et Signalisation, Paris, France
| | - Damarys Loew
- Laboratoire de Spectrométrie de Masse Protéomique, Centre de Recherche, Institut Curie, Université de recherche PSL, Paris, France
| | - Najma Rachidi
- Institut Pasteur and Institut National de Santé et Recherche Médicale INSERM U1201, Unité de Parasitologie Moléculaire et Signalisation, Paris, France
| | - Gerald F Späth
- Institut Pasteur and Institut National de Santé et Recherche Médicale INSERM U1201, Unité de Parasitologie Moléculaire et Signalisation, Paris, France.
| |
Collapse
|